belfasttelegraph Tuesday, 21 October, 2014

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Search news from around the web

  1. Gilead's $1,000-a-pill hepatitis C drug may make financial sense for prisons

    Pricey new hepatitis C drugs, such as Gilead Sciences Inc.'s Sovaldi, may make financial sense to give to give to prisoners, one of the main groups infected with the ... FULL ARTICLE AT San Francisco Business Times

  1. Last week, Gilead Sciences (GILD) finally got the go-ahead on Hepatitis-C treatment Harvoni, which combines Solvaldi with Ledipsavir, and is supposed to cure from 94% to 99% of patients. And ... FULL ARTICLE AT Barron's

  2. Filed under: Investing Source: Johnson & Johnson Johnson & Johnson is one of the planet's biggest drugmakers. Its drugs are used for a variety of diseases, including cancer and autoimmune disorders ... FULL ARTICLE AT Daily Finance

  3. Gilead Sciences (GILD) will report Q3 results on October 28 after the close. The conference call will begin at 1:30 pm PT/4:30 pm ET.Consensus view is ... FULL ARTICLE AT Seeking Alpha

  1. Filed under: Investing Source: Gilead Sciences Gilead Sciences has been the poster child for biotechnology success this year thanks to Sovaldi, its game-changing therapy for hepatitis C. However, there's ... FULL ARTICLE AT Daily Finance

  2. Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Gilead+Sciences+%28GILD%29+Reports+Harvoni+Notice+of+Compliance+in+Canada/9917190.html for the full story. FULL ARTICLE AT Street Insider

  3. Yes, say the folks at Nomura, who recommend buying Celgene (CELG), Receptos (RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya ... FULL ARTICLE AT Barron's

  4. Gilead Sciences (NASDAQ:GILD)‘s stock had its “buy” rating reaffirmed by equities researchers at Nomura in a research report issued on Wednesday. They currently have a $141.00 price ... FULL ARTICLE AT American Banking News

About this topic

Wikipedia

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The... Full Article At Wikipedia.org

Timeline of coverage

  1. Click to see all coverage from 2014-09-06
    2014-09-06
  2. Click to see all coverage from 2014-09-07
    2014-09-07
  3. Click to see all coverage from 2014-09-08
    2014-09-08
  4. Click to see all coverage from 2014-09-09
    2014-09-09
  5. Click to see all coverage from 2014-09-10
    2014-09-10
  6. Click to see all coverage from 2014-09-11
    2014-09-11
  7. Click to see all coverage from 2014-09-12
    2014-09-12
  8. Click to see all coverage from 2014-09-13
    2014-09-13
  9. Click to see all coverage from 2014-09-14
    2014-09-14
  10. Click to see all coverage from 2014-09-15
    2014-09-15
  11. Click to see all coverage from 2014-09-16
    2014-09-16
  12. Click to see all coverage from 2014-09-17
    2014-09-17
  13. Click to see all coverage from 2014-09-18
    2014-09-18
  14. Click to see all coverage from 2014-09-19
    2014-09-19
  15. Click to see all coverage from 2014-09-20
    2014-09-20
  16. Click to see all coverage from 2014-09-21
    2014-09-21
  17. Click to see all coverage from 2014-09-22
    2014-09-22
  18. Click to see all coverage from 2014-09-23
    2014-09-23
  19. Click to see all coverage from 2014-09-24
    2014-09-24
  20. Click to see all coverage from 2014-09-25
    2014-09-25
  21. Click to see all coverage from 2014-09-26
    2014-09-26
  22. Click to see all coverage from 2014-09-27
    2014-09-27
  23. Click to see all coverage from 2014-09-28
    2014-09-28
  24. Click to see all coverage from 2014-09-29
    2014-09-29
  25. Click to see all coverage from 2014-09-30
    2014-09-30
  26. Click to see all coverage from 2014-10-01
    2014-10-01
  27. Click to see all coverage from 2014-10-02
    2014-10-02
  28. Click to see all coverage from 2014-10-03
    2014-10-03
  29. Click to see all coverage from 2014-10-04
    2014-10-04
  30. Click to see all coverage from 2014-10-05
    2014-10-05
  31. Click to see all coverage from 2014-10-06
    2014-10-06
  32. Click to see all coverage from 2014-10-07
    2014-10-07
  33. Click to see all coverage from 2014-10-08
    2014-10-08
  34. Click to see all coverage from 2014-10-09
    2014-10-09
  35. Click to see all coverage from 2014-10-10
    2014-10-10
  36. Click to see all coverage from 2014-10-11
    2014-10-11
  37. Click to see all coverage from 2014-10-12
    2014-10-12
  38. Click to see all coverage from 2014-10-13
    2014-10-13
  39. Click to see all coverage from 2014-10-14
    2014-10-14
  40. Click to see all coverage from 2014-10-15
    2014-10-15
  41. Click to see all coverage from 2014-10-16
    2014-10-16
  42. Click to see all coverage from 2014-10-17
    2014-10-17
  43. Click to see all coverage from 2014-10-18
    2014-10-18
  44. Click to see all coverage from 2014-10-19
    2014-10-19
  45. Click to see all coverage from 2014-10-20
    2014-10-20
  46. Click to see all coverage from 2014-10-21
    2014-10-21

Login

Login to make editorial changes to the current page.

Login Cancel

Close